Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

NIH 3OTHER 2INDUSTRY 1

Study Type

Interventional 6Observational 4

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 1

Conditions

Lymphoma 2571Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia, Lymphocytic, Chronic, B-Cell 1771Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Leukemia 1172Hodgkin Disease 1128Lymphoma, Mantle-Cell 1110Burkitt Lymphoma 887Leukemia, Myeloid, Acute 885Lymphoma, B-Cell, Marginal Zone 788Recurrence 779Multiple Myeloma 744Lymphoma, B-Cell 704Myelodysplastic Syndromes 615Neoplasms 494Lymphoma, T-Cell, Cutaneous 479Waldenstrom Macroglobulinemia 470Lymphoma, Large-Cell, Immunoblastic 456Mycosis Fungoides 383Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Lymphoma, Large-Cell, Anaplastic 362Sezary Syndrome 321Lymphoma, T-Cell, Peripheral 321Leukemia, Myelogenous, Chronic, BCR-ABL Positive 307Hematologic Neoplasms 299Myeloproliferative Disorders 288Neoplasms, Plasma Cell 270Blast Crisis 261

Interventions

transfluthrin 1Quinine 1Artesunate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Malaria × Lymphoid × Clear all
NCT06179732 2024-04-23

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

The Mentor Initiative

Phase 3 Completed
2,400 enrolled
LymphoidOther hematologic neoplasm

Vector Borne Diseases, Malaria, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
900 enrolled
Lymphoid

Burkitt Lymphoma, Malaria

NCT00343005 2017-07-02

Experimental Vaccine for Malaria in Adults in Mali

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
54 enrolled
Lymphoid

Burkitt Lymphoma, Malaria, Malaria, Falciparum

NCT00414336 2017-07-02

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
150 enrolled
Lymphoid

Burkitt Lymphoma, Malaria

NCT01805232 2013-03-06

IVAS

University of Khartoum

Phase 4 Unknown
80 enrolled
Lymphoid

Lymphoma, Follicular, Malaria

NCT00739206 2010-06-16

Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

Sanofi

Phase 2 Terminated
113 enrolled
Lymphoid

Lymphoma, Follicular, Malaria, Malaria, Falciparum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡